Iktos, a company specialized in artificial intelligence (AI) for novel drug design and Astrogen, a clinical and research-oriented biotech company focused in developing innovative new drugs for treatment of intractable neurological diseases today announced that the companies have entered into a research collaboration agreement aimed at discovery of innovative small molecule pre-clinical drug candidates for Parkinson's disease. Under the terms of the agreement, Iktos will apply its proprietary active learning based deep docking and de novo structure-based generative modelling technologies to design and optimize novel compounds and expedite the identification of pre-clinical drug candidates targeting an undisclosed target for the treatment of Parkinson
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!